Zimmer Cash And Equivalents vs Deferred Long Term Liab Analysis

ZBH Stock

USD 110.64 0.32 0.29%

Zimmer Biomet financial indicator trend analysis is more than just analyzing Zimmer Biomet Holdings current accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Zimmer Biomet Holdings is a good investment. Please check the relationship between Zimmer Biomet Cash And Equivalents and its Deferred Long Term Liab accounts. Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Zimmer Biomet Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.

Cash And Equivalents vs Deferred Long Term Liab

Cash And Equivalents vs Deferred Long Term Liab Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Zimmer Biomet Holdings Cash And Equivalents account and Deferred Long Term Liab. At this time, the significance of the direction appears to have no relationship.

The correlation between Zimmer Biomet's Cash And Equivalents and Deferred Long Term Liab is 0.09. Overlapping area represents the amount of variation of Cash And Equivalents that can explain the historical movement of Deferred Long Term Liab in the same time period over historical financial statements of Zimmer Biomet Holdings, assuming nothing else is changed. The correlation between historical values of Zimmer Biomet's Cash And Equivalents and Deferred Long Term Liab is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Cash And Equivalents of Zimmer Biomet Holdings are associated (or correlated) with its Deferred Long Term Liab. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Deferred Long Term Liab has no effect on the direction of Cash And Equivalents i.e., Zimmer Biomet's Cash And Equivalents and Deferred Long Term Liab go up and down completely randomly.

Correlation Coefficient

0.09

Relationship Direction	Positive
Relationship Strength	Insignificant

View All Relationships

Cash And Equivalents

Deferred Long Term Liab

Liabilities that are due after more than one year, including deferred tax liabilities and deferred revenue.

Most indicators from Zimmer Biomet's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Zimmer Biomet Holdings current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Zimmer Biomet Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.

The Zimmer Biomet's current Tax Provision is estimated to increase to about 244.4 M, while Selling General Administrative is projected to decrease to under 2 B.

	2021	2022	2023	2024 (projected)
Gross Profit	4.9B	4.9B	5.3B	3.6B
Total Revenue	6.8B	6.9B	7.4B	5.0B

Gross Profit Total Revenue

Zimmer Biomet fundamental ratios Correlations

	Common Stock Shares Outstanding	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Accounts Payable	Non Current Assets Total	Non Currrent Assets Other	Net Receivables	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Other Liab	Other Assets	Property Plant Equipment	Short Long Term Debt Total	Net Debt	Retained Earnings	Cash	Long Term Debt	Cash And Short Term Investments
Common Stock Shares Outstanding		0.65	0.6	0.75	0.66	0.56	0.74	0.69	0.24	0.55	0.5	0.66	0.33	0.68	0.57	0.23	0.28	0.38	0.04	0.57	0.34	0.64	0.43	-0.5	0.52	-0.7
Total Assets	0.65		0.93	0.86	0.91	0.94	0.9	1.0	0.33	0.95	0.92	0.96	0.57	0.79	0.96	0.32	0.82	0.84	0.27	0.95	0.79	0.95	0.8	0.1	0.93	-0.24
Other Current Liab	0.6	0.93		0.88	0.9	0.92	0.9	0.93	0.3	0.91	0.79	0.9	0.42	0.69	0.86	0.27	0.76	0.69	0.23	0.92	0.59	0.86	0.85	0.03	0.81	-0.24
Total Current Liabilities	0.75	0.86	0.88		0.93	0.84	0.9	0.87	0.55	0.81	0.62	0.88	0.57	0.8	0.73	0.48	0.64	0.51	0.4	0.87	0.44	0.76	0.82	-0.24	0.65	-0.47
Total Stockholder Equity	0.66	0.91	0.9	0.93		0.95	0.92	0.89	0.51	0.91	0.67	0.97	0.62	0.77	0.76	0.52	0.81	0.55	0.51	0.96	0.53	0.76	0.93	-0.01	0.69	-0.26
Property Plant And Equipment Net	0.56	0.94	0.92	0.84	0.95		0.91	0.92	0.37	0.98	0.78	0.97	0.51	0.69	0.84	0.4	0.89	0.7	0.42	1.0	0.66	0.82	0.92	0.19	0.8	-0.1
Accounts Payable	0.74	0.9	0.9	0.9	0.92	0.91		0.91	0.24	0.88	0.73	0.93	0.36	0.83	0.8	0.47	0.65	0.61	0.39	0.9	0.55	0.83	0.78	-0.18	0.75	-0.46
Non Current Assets Total	0.69	1.0	0.93	0.87	0.89	0.92	0.91		0.29	0.93	0.92	0.94	0.54	0.82	0.97	0.32	0.76	0.83	0.24	0.93	0.79	0.97	0.76	0.02	0.93	-0.32
Non Currrent Assets Other	0.24	0.33	0.3	0.55	0.51	0.37	0.24	0.29		0.33	0.09	0.39	0.83	0.23	0.18	0.39	0.49	0.11	0.46	0.43	0.08	0.15	0.56	0.07	0.08	0.03
Net Receivables	0.55	0.95	0.91	0.81	0.91	0.98	0.88	0.93	0.33		0.84	0.94	0.53	0.68	0.88	0.36	0.89	0.77	0.39	0.97	0.69	0.85	0.88	0.2	0.84	-0.09
Non Current Liabilities Total	0.5	0.92	0.79	0.62	0.67	0.78	0.73	0.92	0.09	0.84		0.79	0.43	0.66	0.99	0.09	0.71	0.97	0.01	0.79	0.92	0.97	0.55	0.22	1.0	-0.14
Inventory	0.66	0.96	0.9	0.88	0.97	0.97	0.93	0.94	0.39	0.94	0.79		0.57	0.8	0.85	0.43	0.84	0.69	0.43	0.97	0.68	0.84	0.88	0.08	0.81	-0.23
Other Current Assets	0.33	0.57	0.42	0.57	0.62	0.51	0.36	0.54	0.83	0.53	0.43	0.57		0.47	0.49	0.4	0.65	0.45	0.46	0.58	0.42	0.45	0.59	0.18	0.42	-0.01
Other Stockholder Equity	0.68	0.79	0.69	0.8	0.77	0.69	0.83	0.82	0.23	0.68	0.66	0.8	0.47		0.73	0.65	0.43	0.56	0.48	0.71	0.57	0.78	0.52	-0.35	0.7	-0.66
Total Liab	0.57	0.96	0.86	0.73	0.76	0.84	0.8	0.97	0.18	0.88	0.99	0.85	0.49	0.73		0.16	0.74	0.94	0.09	0.85	0.89	0.99	0.64	0.15	0.99	-0.21
Property Plant And Equipment Gross	0.23	0.32	0.27	0.48	0.52	0.4	0.47	0.32	0.39	0.36	0.09	0.43	0.4	0.65	0.16		0.25	0.05	0.88	0.41	0.07	0.19	0.41	-0.33	0.11	-0.4
Total Current Assets	0.28	0.82	0.76	0.64	0.81	0.89	0.65	0.76	0.49	0.89	0.71	0.84	0.65	0.43	0.74	0.25		0.69	0.39	0.9	0.68	0.66	0.89	0.56	0.71	0.3
Other Liab	0.38	0.84	0.69	0.51	0.55	0.7	0.61	0.83	0.11	0.77	0.97	0.69	0.45	0.56	0.94	0.05	0.69		0.0	0.71	0.93	0.91	0.46	0.32	0.95	-0.03
Other Assets	0.04	0.27	0.23	0.4	0.51	0.42	0.39	0.24	0.46	0.39	0.01	0.43	0.46	0.48	0.09	0.88	0.39	0.0		0.43	0.0	0.07	0.51	-0.02	0.03	-0.08
Property Plant Equipment	0.57	0.95	0.92	0.87	0.96	1.0	0.9	0.93	0.43	0.97	0.79	0.97	0.58	0.71	0.85	0.41	0.9	0.71	0.43		0.66	0.83	0.93	0.18	0.8	-0.11
Short Long Term Debt Total	0.34	0.79	0.59	0.44	0.53	0.66	0.55	0.79	0.08	0.69	0.92	0.68	0.42	0.57	0.89	0.07	0.68	0.93	0.0	0.66		0.85	0.41	0.39	0.91	0.02
Net Debt	0.64	0.95	0.86	0.76	0.76	0.82	0.83	0.97	0.15	0.85	0.97	0.84	0.45	0.78	0.99	0.19	0.66	0.91	0.07	0.83	0.85		0.59	0.01	0.98	-0.34
Retained Earnings	0.43	0.8	0.85	0.82	0.93	0.92	0.78	0.76	0.56	0.88	0.55	0.88	0.59	0.52	0.64	0.41	0.89	0.46	0.51	0.93	0.41	0.59		0.24	0.57	0.05
Cash	-0.5	0.1	0.03	-0.24	-0.01	0.19	-0.18	0.02	0.07	0.2	0.22	0.08	0.18	-0.35	0.15	-0.33	0.56	0.32	-0.02	0.18	0.39	0.01	0.24		0.18	0.92
Long Term Debt	0.52	0.93	0.81	0.65	0.69	0.8	0.75	0.93	0.08	0.84	1.0	0.81	0.42	0.7	0.99	0.11	0.71	0.95	0.03	0.8	0.91	0.98	0.57	0.18		-0.18
Cash And Short Term Investments	-0.7	-0.24	-0.24	-0.47	-0.26	-0.1	-0.46	-0.32	0.03	-0.09	-0.14	-0.23	-0.01	-0.66	-0.21	-0.4	0.3	-0.03	-0.08	-0.11	0.02	-0.34	0.05	0.92	-0.18

Click cells to compare fundamentals

Zimmer Biomet Account Relationship Matchups

Zimmer Biomet fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Common Stock Shares Outstanding	206.7M	207M	210.4M	210.3M	209.7M	164.9M
Total Assets	24.6B	24.4B	23.5B	21.1B	21.5B	13.7B
Other Current Liab	1.9B	1.4B	1.5B	1.4B	1.4B	1.0B
Total Current Liabilities	3.4B	2.6B	3.5B	2.4B	2.9B	1.5B
Total Stockholder Equity	12.4B	12.2B	12.7B	12.0B	12.5B	7.4B
Property Plant And Equipment Net	2.1B	2.0B	1.8B	1.9B	2.3B	1.4B
Accounts Payable	400.9M	330M	306.5M	354.1M	410.6M	229.9M
Non Current Assets Total	19.9B	19.3B	18.6B	16.6B	16.9B	10.3B
Non Currrent Assets Other	980.1M	969.4M	2.3B	630.8M	916.7M	577.3M
Net Receivables	1.4B	1.5B	1.3B	1.4B	1.4B	975.8M
Liabilities And Stockholders Equity	24.6B	24.4B	23.5B	21.1B	21.5B	13.7B
Non Current Liabilities Total	8.8B	9.7B	7.3B	6.7B	6.2B	4.8B
Inventory	2.4B	2.5B	2.1B	2.1B	2.4B	1.4B
Other Current Assets	357.1M	741.9M	1.1B	522.9M	366.1M	401.6M
Other Stockholder Equity	2.2B	2.4B	2.6B	2.6B	2.3B	2.4B
Total Liab	12.2B	12.2B	10.8B	9.0B	9.0B	6.3B
Property Plant And Equipment Gross	2.1B	2.0B	6.1B	6.5B	6.8B	7.1B
Total Current Assets	4.7B	5.1B	4.9B	4.4B	4.6B	3.4B
Accumulated Other Comprehensive Income	(241.9M)	(297.8M)	(231.6M)	(179.3M)	(191M)	(181.5M)
Other Liab	1.9B	2.0B	1.9B	1.1B	1.3B	1.2B
Other Assets	652.9M	969.4M	1.1B	1.1B	1.3B	1.4B
Property Plant Equipment	2.1B	2.0B	2.0B	1.9B	2.2B	1.4B
Short Long Term Debt Total	8.2B	8.1B	7.1B	5.7B	6.0B	4.8B
Net Debt	7.6B	7.3B	6.7B	5.3B	5.6B	3.7B
Retained Earnings	10.4B	10.1B	10.3B	9.6B	10.4B	6.8B
Cash	617.9M	802.1M	378.1M	375.7M	415.8M	591.2M
Long Term Debt	6.7B	7.6B	5.5B	5.2B	5.0B	4.0B
Cash And Short Term Investments	617.9M	802.1M	378.1M	375.7M	415.8M	732.9M
Short Term Debt	1.5B	575M	1.6B	544.3M	952.9M	1.3B
Good Will	9.6B	9.3B	8.9B	8.6B	8.8B	6.0B
Intangible Assets	7.3B	7.1B	5.5B	5.1B	4.9B	4.2B
Treasury Stock	(6.7B)	(6.7B)	(6.7B)	(6.9B)	(6.2B)	(6.5B)
Net Tangible Assets	(4.5B)	(4.1B)	(2.8B)	(1.6B)	(1.5B)	(1.5B)
Noncontrolling Interest In Consolidated Entity	4.7M	5.2M	5.7M	6.7M	6.0M	5.7M
Retained Earnings Total Equity	10.4B	10.1B	10.3B	9.6B	11.0B	9.1B
Capital Surpluse	8.9B	9.1B	9.3B	9.5B	10.9B	7.5B

Currently Active Assets on Macroaxis

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America
S	SentinelOne
WD	Walker Dunlop

When determining whether Zimmer Biomet Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Zimmer Biomet's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Zimmer Biomet Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Zimmer Biomet Holdings Stock:

How To Invest In Zimmer

Details

Is Zimmer Stock a good investment?

Details

What is Zimmer Biomet's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Zimmer Biomet Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.

You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Zimmer Biomet. If investors know Zimmer will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Zimmer Biomet listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

0.597

Dividend Share

0.96

Earnings Share

5.24

Revenue Per Share

37.006

Quarterly Revenue Growth

0.04

The market value of Zimmer Biomet Holdings is measured differently than its book value, which is the value of Zimmer that is recorded on the company's balance sheet. Investors also form their own opinion of Zimmer Biomet's value that differs from its market value or its book value, called intrinsic value, which is Zimmer Biomet's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Zimmer Biomet's market value can be influenced by many factors that don't directly affect Zimmer Biomet's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Zimmer Biomet's value and its price as these two are different measures arrived at by different means. Investors typically determine if Zimmer Biomet is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Zimmer Biomet's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Zimmer Cash And Equivalents vs Deferred Long Term Liab Analysis

Cash And Equivalents vs Deferred Long Term Liab

Cash And Equivalents vs Deferred Long Term Liab Correlation Analysis

Correlation Coefficient

Cash And Equivalents

Deferred Long Term Liab

Zimmer Biomet fundamental ratios Correlations

Zimmer Biomet Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Zimmer Biomet fundamental ratios Accounts

Currently Active Assets on Macroaxis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Non Current Assets Total	+ 1.0	Total Assets
Property Plant Equipment	+ 1.0	Property Plant And Equipment Net
Long Term Debt	+ 1.0	Non Current Liabilities Total
Total Liab	+ 0.99	Non Current Liabilities Total
Net Debt	+ 0.99	Total Liab
Long Term Debt	+ 0.99	Total Liab

Cash And Short Term Investments	- 0.7	Common Stock Shares Outstanding
Cash And Short Term Investments	- 0.66	Other Stockholder Equity
Cash	- 0.5	Common Stock Shares Outstanding
Cash And Short Term Investments	- 0.47	Total Current Liabilities
Cash And Short Term Investments	- 0.46	Accounts Payable
Cash And Short Term Investments	- 0.4	Property Plant And Equipment Gross